互动平台策划“自问自答”，英集芯被证监会立案调查

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has announced an investigation into Yingjixin for misleading statements made during a Q&A session on the Shanghai Stock Exchange's E-interaction platform, emphasizing the need to maintain healthy market development [1]. Group 1: Company Developments - On January 6, 2026, Yingjixin responded to an investor inquiry regarding its involvement in the brain-computer interface (BCI) market, stating that it has entered this field through early investments and has launched the IPA1299 chip, which is designed for high-precision measurement of biological electrical signals [3]. - The IPA1299 chip is an 8-channel, low-noise 24-bit ADC chip that has already been mass-produced and is comparable in performance to leading overseas chip products [3]. - Yingjixin expressed confidence in the broad application prospects of brain-computer interfaces and plans to continue investing resources to achieve breakthroughs in related technologies [3]. Group 2: Market and Regulatory Response - On January 7, Yingjixin provided further clarification, noting that the IPA1299 product is still in the market cultivation phase for non-invasive brain-computer interfaces and has not yet achieved significant sales, which has not materially impacted the company's performance [4]. - Despite acknowledging the uncertainties surrounding this business, Yingjixin's stock rose by 4.51% on January 7 [5]. - The Shanghai Stock Exchange promptly issued a regulatory warning to Yingjixin and its then-secretary of the board, Wu Renchao, following the misleading statements [5]. Group 3: Company Background - Yingjixin was established in 2014 and went public on the Sci-Tech Innovation Board in 2022. Its main business includes power management chips, fast charging protocol chips, data transmission processing chips, wireless signal processing chips, and smart audio-video chips, with applications across various consumer electronics and automotive electronics [5].